Fig. 3From: Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims databaseMedical costs PPPM for inpatient (without DMT), DMT, and other outpatient costs by calendar year. The percentage of DMT cost increased from 27 to 51% (P < 0.001), and that of inpatient cost decreased from 49 to 29% (P < 0.001) when comparing 2008 with 2016. DMT, disease-modifying therapy; PPPM, per patient per monthBack to article page